BRAIN Biotech AG And Akribion Therapeutics Gmbh Sign Exclusive Pharma Licensing Agreement For G-Dase E® CRISPR-Cas Technology

(MENAFN - EQS Group) EQS-News: BRAIN Biotech AG / Key word(s): ContractBRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase E– ...

By: menafn